Share

    


Home / Search Results

Search Results

Search Publications

Search Again?

Filter By Content Type

Filter By Topic

ACCCBuzz shares a brief on the its" Digital Bridges: Optimizing Telehealth for Older Adults With Cancer," including more about the benefits of developing a telehealth-based geriatric oncology clinic.
Click to enter a date Choose an item Enter First & Last Name [ INSERT YOUR COMPANY’S NAME HERE] Dear Choose an item Enter your last name The Montana State Oncology Society (MSOS) Board of Directors invites [ INSERT YOUR COMPANY’S NAME HERE] to attend and display among one of our MSOS Education Series. The $2,500 registration fee includes: ⊳ draped display table, no electricity …
Form W-9 (Rev. October 2018) Department of the Treasury Internal Revenue Service Request for Taxpayer Identification Number and Certification ▶ Go to www.irs.gov/FormW9 for instructions and the latest information. Give Form to the requester. Do not send to the IRS. P ri nt o r ty p e. S ee S p ec ifi c In st ru ct io ns o n p ag e …
Now in its 40th year, the Chemotherapy Foundation Symposium® (CFS®) brings together thousands of health care professionals for an exciting 3-day conference that promotes the delivery of evidence-based, state-of-the-art cancer care. Internationally renowned faculty will discuss the latest developments in cancer therapeutics, offering you a unique opportunity to learn how innovative approaches …
Updates in Diffuse Large B-cell Lymphoma Brian Hess, MD Assistant Professor, Hematology/Oncology Medical University of South Carolina/Hollings Cancer Center Disclosure of Conflicts of Interest Brian Hess, MD, has the following financial relationships to disclose: •Consultant: ADC Therapeutics •Speaker: BMS Agenda • Update of frontline trials in DLBCL …
Breast Cancer: Updates, Advances, and New Treatment Options Antoinette R. Tan, MD, MHSc, FACP Chief of Breast Medical Oncology Chief of Solid Tumor and Investigational Therapeutics Levine Cancer Institute, Atrium Health, Charlotte, NC August 6, 2022 Disclosure of Conflicts of Interest Antoinette R. Tan, MD, MHSc, FACP has the following financial relationships to …
Lung Cancer Advances Jimmy Ruiz, MD Associate Professor of Medicine Atrium Health Wake Forest Baptist Comprehensive Cancer Center Disclosure of Conflicts of Interest Jimmy Ruiz, MD has no relevant financial relationships to disclose. Advances in Metastatic NSCLC Biomarkers Precision Oncology Immunotherapy Lung Cancer • 2.2 million new cases and …
CardioOncology: Advancing the Cardiovascular Care of the Oncology Patient CardioOncology: Advancing the Cardiovascular Care of the Oncology Patient David Reeves, PharmD, BCOP Associate Professor & Clinical Pharmacy Specialist Butler University & Franciscan Health Vijay U. Rao, MD, PhD, FACC, FASE, FHFSA, FICOS Director, Franciscan Health CardioOncology International Cardio-Oncology …
PowerPoint Presentation Revenue Cycle State of the State INDIANA – August 2022 Bobbi Buell, MBA Cassidy Lewis Summer, 2022 bbuell@onpointoncology.com Bobbibuell1@yahoo.com NEWSLETTER: www.onpointoncology.com Disclaimer and Introductions • Nothing in this presentation is to promote off-label use of any particular product or service. • No drug manufacturer sponsored …
PowerPoint Presentation Practical Strategies to Avoid Burnout, and How to Help Build Resilience in Your Team Jennifer Bires, LCSW, OSW-C Executive Director Life with Cancer and Patient Experience How to keep walking forward, and even find renewal along the way, in this year of things blown apart? What sustains us? How to hold on to our sense of what …
Advancing Medicine Through Advocacy INTRODUCTIONS Darra Coleman – Special Counsel, Nexsen Pruet Holly Pisarik – Sr. Vice President of Advocacy and Policy Counsel, SC Medical Association WHY DOES ADVOCACY MATTER? • Last legislative session (2021-2022), 15% of the 1800 bills filed pertained to the practice of medicine in some way • Wide range of topics – COVID …
CLL and Frontline Therapies James Davis, PharmD, BCOP Assistant Professor – MUSC College of Pharmacy Clinical Pharmacist – MUSC Hollings Cancer Center Email: Davisjaa@musc.edu @thisisJamesD Disclosure of Conflicts of Interest James Davis, PharmD, BCOP has no relevant financial relationships to disclose. Exploring Upfront Treatment Options in CLL Objectives …
New Guidelines on Localized Prostate Cancer Management Daniel A. Barocas, MD, MPH Disclosure of Conflicts of Interest Daniel A. Barocas, MD, MPH has the following financial relationships to disclose: • Industry • Advisory Boards: Ambu, Lantheus, Pacific Edge • Consulting: Optum Health • Research funding • NCI • Movember Foundation Clinically Localized Prostate …
Enhancing Equity in Clinical Research: Lessons from Community Oncology Engagement Efforts South Carolina Oncology Society Annual Meeting 6 August 2022 Dr. Richard Lewis Martin III, MD, MPH (he/him/his) Tennessee Oncology Disclosure of Conflicts of Interest • Funding • U54 CA0914010 (NCI) • 09/01/2021-08/31/2025 • Meharry-Vanderbilt-TSU Cancer Partnership • …
Chelsea Osterman, MD Genitourinary Medical Oncologist Mission Medical Oncology, Asheville, NC Multidisciplinary Management of Bladder Cancer: Improving Guideline-Concordant Care DISCLOSURE OF CONFLICTS OF INTERESTS Chelsea Otterman, MD, has the following financial relationships to disclose: Consultant: Pfizer/Myovant Science Click to add text …
Learn how ACCC's bispecific antibody initiative “Best Practices in Expanding Access to Bispecific Antibodies and Adverse Event Management”—developed in partnership with the Society for Immunotherapy of Cancer—will help expand the use of these novel therapies and optimize care for patients with cancer.
Conversation Guide: Biomarker Testing and its Role in Your Cancer Journey What biomarker testing is recommended for the specific type of cancer I have? Have any of these tests already been done? If so, what do they show? What steps do I need to take to get any additional recommended biomarker testing? How will the results be used to guide my cancer care? Who can I talk to if I have …
Results from biomarker testing can help providers: • Detect, stage, or classify cancer • Assess how quickly the cancer may grow or spread • Determine what targeted therapies are more or less likely to work • Assess a patient’s risk of cancer and cancer recurrence Results from biomarker testing can help patients: • Obtain information about their cancer risk • Understand their specific …
Provider Education Many providers indicate that more education about published guidelines and financial assistance for patients are needed to help them make decisions about biomarker testing in lung cancer.1 Incorporate Education Offer educational opportunities about biomarker testing and lung cancer for the multidisciplinary team to keep up with evolving recommendations and changes in …